Last reviewed · How we verify
NCT07494110: Aurora
Aurora: AI-Based Narrative Intervention to Support Emotional Well-Being in Clinical and Non-Clinical Populations
NA trial testing chatbot-mediated supportive care intervention in Institutionalization in 55 participants. Currently enrolling.
1 April 2026
Quick facts
| Lead sponsor | Universitat Autonoma de Barcelona |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 55 |
| Start date | 12 February 2026 |
| Primary completion | 1 April 2026 |
| Estimated completion | 1 April 2026 |
| Sites | 2 locations across Spain |
Drugs / interventions tested
- chatbot-mediated supportive care intervention
Conditions studied
- Institutionalization — all drugs for Institutionalization →
- Elderly — all drugs for Elderly →
- Mental Health — all drugs for Mental Health →
- Wellbeing — all drugs for Wellbeing →
Sponsor
Universitat Autonoma de Barcelona
Who can join
18 and older, any sex, with Institutionalization or Elderly. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aurora is an interdisciplinary project evaluating a chatbot-mediated supportive care intervention designed to promote emotional expression, autobiographical meaning-making, identity processes, and emotional well-being through guided narrative reconstruction. The Aurora system provides a structured, person-centered storytelling process supported by generative AI and human facilitation. Under the supervision of a trained facilitator (licensed mental health professional), participants engage in guided reminiscence and storytelling sessions to co-create a personalized "life book." The chatbot is not a diagnostic or treatment tool; rather, it is intended to support emotional expression, narrative reconstruction, and recovery-oriented processes. The study includes three non-randomized arms implemented sequentially: (1) a single-session arm of healthy adults focused on acceptability, usability, and emotional safety; (2) a four-hour intervention arm of adults with DSM-5 diagnosed mental disorders in residential care; and (3) a four-hour intervention arm of healthy older adults aged 65 years and older. Quantitative outcomes assess affect, mental well-being, and recovery-related constructs. Additional measures include usability, satisfaction, and qualitative feedback. Ecological momentary assessment (EMA) is conducted in Arms 2 and 3.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07494110
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Universitat Autonoma de Barcelona trials
Trials by the same sponsor.
- NCT06270732 — Efficacy of iMentalize and MISC-SA to Foster Parents' Mentalization and Children Mental Health in General Population. · NA · unknown
- NCT06150313 — Efficacy of the Mediational Intervention for Sensitizing Caregivers for Teachers and Self-Administered Versions · NA · unknown
- NCT06423651 — Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders · NA · recruiting
- NCT04877405 — Retrospective Study of Intracerebral Hemorrhage Patients in Hospital Parc Taulí · completed
- NCT04153500 — Validation of a Female Pelvic Floor Interactive Training Model · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07494110 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitat Autonoma de Barcelona
- Last refreshed: 27 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07494110.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing